Latest News - Personnel/Company News

Tuesday, February 27, 2018

Kenneth Marek, MD Joins the Michael J. Fox Foundation for Parkinson's Research as Scientific Advisor

The Michael J. Fox Foundation for Parkinson's Research (MJFF) announced that Kenneth Marek, MD, has joined the Foundation as Scientific Advisor. In this role, Dr. Marek will provide more dire…

Read the full story

Tuesday, October 24, 2017

Neural Analytics Partners with Department of Defense to Develop Portable Device to Assess Combat-Related TBI

The Department of Defense (DoD) has awarded Neural Analytics, Inc. a $10 million contract to develop and supply a portable, point-of-injury device for assessing combat-related traumatic brain inj…

Read the full story

Tuesday, August 08, 2017

Recently Approved ALS Treatment Radicava Now Available

Radicava (edaravone, Mitsubishi Tanabe Pharma America), an intravenous therapy indicated for all adult patients diagnosed with amyotrophic lateral sclerosis (ALS), is now available for treatment in th…

Read the full story

Monday, April 24, 2017

Elekta: New Data on Stereotactic Neurosurgery Devices Presented at AANS

Elekta's Leksell Gamma Knife® radiosurgery system has been highlighted in more than 15 scientific presentations at the American Association of Neurological Surgeons (AANS) Annual Meeting&…

Read the full story

Thursday, January 19, 2017

Takeda and Ovid Strike Partnership to Develop Investigational Agent for Rare Pediatric Epilepsy

Takeda and Ovid Therapeutics are teaming up for the clinical development and commercialization of Takeda’s investigational new drug TAK-935, a novel CH24H inhibitor, in rare pediatric epilepsies…

Read the full story

Wednesday, January 18, 2017

Lilly to Acquire Migraine Drug Maker CoLucid

Eli Lilly and Co. is set to acquire CoLucid Pharmaceuticals for $960 million. CoLucid is currently developing lasmiditan, a migraine medicine that could help patients with cardiovascular disease.…

Read the full story

Wednesday, May 11, 2016

Alzheimer's Advocacy Foundations Partner on $10 Million Initiative for Development of Treatments for Frontotemporal Degeneration

The Alzheimer’s Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Degeneration (AFTD) are teaming up on a $10 million investment to develop effective treatments for frontotempo…

Read the full story

Thursday, April 07, 2016

Pfizer and IBM Teaming Up On Remote Monitoring System for Parkinson’s Disease

Pfizer Inc. and IBM are joining forces to develop innovative remote monitoring solutions aimed at transforming how clinicians deliver care to patients suffering from Parkinson’s disease. The experim…

Read the full story

Wednesday, March 23, 2016

Mobile Stroke Unit with Advanced CT Imaging Capabilities Launched in Tennessee

The University of Tennessee College of Medicine in Memphis, Tenn. recently introduced a comprehensive mobile stroke unit capable of conducting and producing advanced quality imaging for stroke diagnos…

Read the full story

Wednesday, March 23, 2016

PCORI Seeking Advisory Panel Members

The Patient-Centered Outcomes Research Institute (PCORI) has openings for researchers, clinicians and others on seven Advisory Panels and has extended its nomination/application deadline to March 31. …

Read the full story

Friday, February 19, 2016

Edge Therapeutics Presents Positive Data for Aneurysmal Subarachnoid Hemorrhage Agent

At the International Stroke Conference in Los Angeles, Edge Therapeutics, Inc. presented positive data supporting the potential pharmacoeconomic impact of its lead product candidate EG-1962 for the tr…

Read the full story

Thursday, February 18, 2016

Codman Neuro Unveils Vascular Reconstruction Device for Wide-Necked Aneurysms

Codman Neuro has launched the Codman Enterprise 2 Vascular Reconstruction Device, the latest generation of the company’s self-expanding stent and delivery system used to treat wide-necked intracrani…

Read the full story

Wednesday, February 10, 2016

Biogen Donates $5 Million to Target ALS Foundation

Target ALS Foundation, a collaborative research consortium focused on discovering treatments and a cure for ALS, has received a $5 million donation from Biogen that will fund critical ALS research acr…

Read the full story

Wednesday, January 27, 2016

Lilly and Roche Diagnostics Partnering on Alzheimer's Disease Adjunct Diagnostic Tool

Eli Lilly and Company and Roche Diagnostics are partnering on the ongoing development of a commercially scalable cerebrospinal fluid assay for amyloid-beta 1-42. Under the non-exclusive agreement, Lil…

Read the full story
Load More